Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.

Subjects

Subjects :

Female
Humans
Male
Hematopoietic Stem Cell Transplantation mortality
Invasive Pulmonary Aspergillosis mortality
Mannans blood

Details

Language :

English

ISSN :

1537-6591

Volume :

57

Issue :

12

Database :

MEDLINE

Journal :

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication Type :

Editorial & Opinion

Accession number :

24046295

Full Text :

https://doi.org/10.1093/cid/cit565